Sponsors & exhibitors

Cryoport Systems is the trusted global provider of temperature-controlled logistics and supply chain solutions for life sciences commodities during distribution, serving the biopharmaceutical market with leading-edge solutions for biologic...

Assurea is a firm known for quality compliance and Data Integrity expertise within novel therapies in the global life sciences industry. We have built a model that is collaborative, flexible and accelerates the path forward for our partners to serve ...

Bionamic is a software platform for drug research and development. The platform is built from the ground up to empower researchers to accelerate the discovery and development of antibodies and other biomolecules. Bionamic is used as a single source...

BIOTTS S.A. is a Polish biotechnology company that develops proprietary drug technologies and drug formulations in the fields of oncology, diabetology and dermatology. Based on unique manufacturing technologies and new approach to substance...

ClexBio is a regenerative medicine company developing novel tissue-engineered solutions to treat various clinical conditions. The first product in the company’s pipeline is a human acellular vein graft to restore valve function and permanently treat ...

We are developing an approach for human natural killer (NK) cell immunotherapy that involves an off-the-shelf CAR NK cell that enables the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Our NK cell...

Helex is accelerating next generation CRISPR based cell and gene therapy companies to market through its technology that enables better control over genome editing by precision engineering the programmable component of the CRISPR/Cas system- the...

Capitalizing on a 65-year legacy of cold chain storage and transport technology, IC Biomedical is bringing new life to the cryogenic equipment world. IC Biomedical builds the highest-quality cryogenic storage and transport systems for the global...

LightOx is headquartered in Newcastle upon Tyne, UK and is developing new light activated drug compounds for the treatment of early stage and pre-cancerous lesions and is currently completing pre-clinical testing.LightOx's lead candidate will...

Neobe Therapeutics is an early stage startup spun out of a collaboration between Deep Science Ventures and Cancer Research UK to address tumour microenvironment constraints to therapeutic efficacy. Only around 20% of patients with solid tumors are...

NETRI is a company developing innovative technologies for the pharmaceutical industry. Its patented organ-on-a-chip technologies allow the creation of standardized, human and predictive in vitro models. This allows to anticipate the efficacy of an...

Current gene therapies are mostly limited to plasmid-based and Adeno-associated virus variants with inefficient response rates and limited use.  Better viral delivery methods would expand the available gene therapy tool kit to produce precision...

Building on a foundation of expertise in cancer research and medical device development, Verinnogen looks to tackle one of the biggest unmet technological needs in pre-clinical cancer research: quick and accurate estimation of subcutaneous tumour...

evorion biotechnologies has developed its innovative CellCity System and high-tech tools that enable multi-modal analyses of thousands of cell-cell interactions in a 3D microenvironment at single-cell resolution. For the first time, researchers can...

Sarcura develops a cutting-edge device platform to scale global manufacturing capacity, enabling cost effective and safe cell therapies. We will transform existing manufacturing paradigms by using semiconductor technology to bring bioprocess control ...

CELLORAMA, Milton, MA, USAProtect and Discover Cells with Novel TechnologiesCELLORAMA was established in 2020 to provide technologies for a healthy and safe environment for patients ‘samples in the lab. We bring solutions to protect sensitive and...

Lentivirus is commonly used as a vector for gene addition due to its ability to deliver relatively large payloads that stably integrate into the host genome.  This vector is clinically and commercially employed in direct gene therapy applications or ...

Vivan Therapeutics, a UK based company, offers personalised cancer therapeutics utilising technology developed at and in partnership with Mt Sinai Medical Centre.  We identify personalised cancer treatments for patients based on their tumour...

Stem Genomics is a French biotechnology specialized in designing innovative testing technologies dedicated to stem cells. We are a spin-out of the Institute of Regenerative Medicine and Biotherapy (IRMB) and co-founded by Prof. John de Vos and...

coding.bio is building best-in-class cell therapies through automation & computation.

Pleco Therapeutics is a Dutch private limited company, established to develop a portfolio of therapies in the field of cancer medicine. Pleco utilises a global network of academic centres and contract research organisations to test highly-efficient...

We build products to enhance cell culture and improve quality of life. At denovoMATRIX we deploy our modular, biomimetic coating technology to enable high performance cell culture, bringing cell therapies to patients and accelerating the path to...

Assay Genie’s mission is simple! To make scientists smile through innovative & unique assay & antibody technologies, quirky marketing and personal interactions with our team.But what does Assay Genie do? Assay Genie is a global life science...

Visicell, “GPS for cell therapy”, provides non-invasive, imaging-based cell tracking solutions to customers in a multi-billion-dollar cell therapy industry. Our patent-pending solutions arm users with early and rapid clinical information for timely...

Arcanabio develops technologies and offers state of the art diagnostics services that allow for ultra fast screening of hard to detect DNA data. We provide our clients with a complete digital biosurveillance platform and dna testing service where...

Biomedical data and software solutions for the age of machine intelligenceWe specialise in providing tools and services to solve problems at the intersection of medicine and ML/AI. From data acquisition, building infrastructure and processes to...

MicrofluidX is tackling the problems of process control, scalability, and cost associated with cell bioprocessing, in particular for autologous cell and gene therapy. Its automated, closed bioprocessing platforms allows scientists to easily carry...

Novasign uses advanced machine learning algorithms (mainly hybrid models) to better and faster describe bioprocesses. Our customers are mainly in early stage development (up- and downstream) aiming to optimize their bioprocesses with less...

MyCellHub is the European leader in biomanufacturing process digitalisation strategy, helping democratise access to innovative therapies by supporting those who develop them. Digital lab and cleanroom workflows now play a critical part in therapy...

Digi.Bio is a digital biology company working at the intersection of biology, computation and engineering to develop cheaper, faster, and smarter automation tools that accelerate life science discoveries. Today, Digi.Bio is building a bench-top...

Matricelf is a biotechnology company in the field of tissue engineering. The company develops a platform for autologous (personal) 3D printing of tissues and organs that significantly reduce the risk of implant rejection. Using a single biopsy from...

Saparo Translational Research combines preclinical models and know-how with anatomical, physiological, and molecular imaging to provide tailored study design and execution for your advanced medical therapy or device evaluation. We put our focus to...

EVerZom is a French biotech company, developing the first CDMO dedicated to exosomes. Based on a patented technology and over 10 years of academic research in nano and biotechnologies, EVerZom has developed an innovative large-scale exosome...

Mytos develops cell culture automation technology to accelerate drug discovery. Our machines use robotic automation to maintain and expand adherent and suspension cultures, allowing teams to save time & resources on cell culture.

The privately held precision immunotherapy company Alithea Bio UG was founded in 2019 in Freiburg, Germany. Its main goal is the support innovativations like TCR T cell therapy and cancer vaccines. Alithea is partnering its highly sensitive and...

Carcinotech is a MedTech Contract Manufacturing organisation with expertise in manufacturing 3D printed mini tumours using patient-derived cancer stem cells, primary cells and established cell lines. Carcinotech’s advanced models provide a platform...

Cenya Imaging BV is addressing the need to measure the biodistribution of cell therapies in humans and other species by developing Cenya BEACONs, an imaging agent. BEACONs can passively label a wide range of cell types (eg dendritic cells, T...

Nanotein Technologies, Inc. is a fast-moving startup company from Berkeley, California, that has innovated a best-in-class T cell activation and expansion reagent for the CAR-T industry. This reagent generates more T cells per unit time, while...

SENISCA is a discovery stage, oligonucleotide therapeutics spinout from the University of Exeter, founded in 2020. Our founders are world leaders in molecular and cellular biology and have patent-protected an innovation for the reversal of cellular...

3D Bio-Tissues (3DBT) is a biotechnology start-up spun-out from Newcastle University. Founded by Professor Che Connon and Dr. Ricardo Gouveia in 2019, 3DBT aims to produce biological equivalent tissues for clinical and consumer use. Tissue...

lino Biotech AG is the world’s only company specialized in focal molography – an entirely new method for measuring molecular interactions in living cells or crude biological samples. The broadly patented technology offers label-free detection assays ...

At Sorbus Biomedical, we develop technical solutions for cell cultivation that goes beyond the capabilities of current day standardized equipment. Overcoming limitations of traditional equipment in the lab environment, our cultivation technology...

Luminary is a clinical-stage gene modified cellular therapy development company. We expect to launch our first clinical trial in Q1-2022 with a novel 3 receptor Ligand CAR designed to overcome antigen escape. The primary focus of the company is...

REM Analytics is developing the next generation of microbiome analysis. We developed a unique technology for profiling human microbiomes quantitatively and comprehensively with strain level resolution. Using our analytical know-how, we provide...

At SEED Biosciences we make DISPENCELL, an automated laboratory instrument designed for fast, easy, and gentle single cell isolation.DISPENCELL is a pipetting robot designed to be compact, gentle, and intuitive, yet compliant with the most stringent ...

ImmuMap is a Danish CRO dedicated to advancing the use and quality of flow cytometry- and immunospot-based monitoring of cellular immunity. We offer flexible, cost-effective, and bespoke state-of-the-art services for assessment and analysis of...

Drishti Discoveries is an early-stage gene therapy company building a platform to develop disease-modifying treatments for rare diseases. Using bioinformatics and machine learning tools we are identifying novel targets and developing drug candidates ...

Rinri Therapeutics Ltd. is a therapeutic discovery and development company working to develop advanced therapies for hearing loss, a global condition affecting millions with no approved therapies and poor patient outcomes.  Rinri is leveraging its...

Semarion is a spin-out company from the Cavendish laboratory at Cambridge University. We are reimaging adherent cell assays through our proprietary SemaCytes® microcarrier platform. These flat carriers are developed using microchip fabrication...